FOI_7062

Internal Reference Number: FOI_7062

Date Request Received: 08/03/2023 00:00:00

Date Request Replied To: 03/04/2023 00:00:00

This response was sent via: By Email

Request Summary: Treatment for Myelofibrosis

Request Category: Companies


Question Number 1: How many patients were treated in the past 6 months (for any disease) with: • Ruxolitinib • Fedratinib

Answer To Question 1: * Ruxolitinib - 7 * Fedratinib - 0

Question Number 2: Does your trust treat myeloproliferative neoplasms? If not, which other trust do you refer these patients to?

Answer To Question 2: Yes, don't refer on except specific complex or trial patients

Question Number 3: Please provide the total number of patients treated in the last 6 months for: • Polycythaemia Vera (ICD10 code D45) • Myelofibrosis (ICD10 code D47.4) • Myelofibrosis (ICD10 code D47.4) patients aged 65 and older

Answer To Question 3: PV 0 MF 0 MF 65/+0

Question Number 4: Of the patients treated in the past 6 months with Ruxolitinib, how many patients had a diagnosis for: • Polycythaemia Vera (ICD10 code D45) • Myelofibrosis (ICD10 code D47.4)

Answer To Question 4: PV 0 MF 0

Question Number 5: How many myelofibrosis (ICD10 code D47.4) patients has your trust diagnosed in the past 3 years? • Of the patients diagnosed with myelofibrosis in the past 3 years, how many were treated in the past 6 months with Hydroxycarbamide? • Of the patients diagnosed with myelofibrosis in the past 3 years, how many were treated in the past 6 months with Interferon therapy? • Of the patients diagnosed with myelofibrosis in the past 3 years, how many have received no active treatment in the past 6 months?

Answer To Question 5: How many myelofibrosis (ICD10 code D47.4) patients has your trust diagnosed in the past 3 years? <10 Of the patients diagnosed with myelofibrosis in the past 3 years, how many were treated in the past 6 months with Hydroxycarbamide? <5 Of the patients diagnosed with myelofibrosis in the past 3 years, how many were treated in the past 6 months with Interferon therapy? 0 Of the patients diagnosed with myelofibrosis in the past 3 years, how many have received no active treatment in the past 6 months? <5

To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.